Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2016 by Columbia University
Information provided by (Responsible Party):
Diane George, MD, Columbia University Identifier:
First received: February 11, 2014
Last updated: July 26, 2016
Last verified: July 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2018
  Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)